Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)
Clinical Study Evaluating the Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy (LSG) for Morbid Obese Patients
Sponsor: Tanta University
Listed as NCT06254183, this PHASE4 trial focuses on Acute Kidney Injury and Obesity (BMI > 35) and remains completed. Sponsored by Tanta University, it has been updated 8 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Phase: PHASE1/PHASE2 → PHASE4
-
Oct 2025 — Feb 2026 [monthly]
Completed PHASE1/PHASE2
Status: Active Not Recruiting → Completed
-
May 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Not Yet Recruiting → Active Not Recruiting
-
Dec 2024 — May 2025 [monthly]
Not Yet Recruiting PHASE1/PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE1/PHASE2
▶ Show 3 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2024 — May 2024 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Tanta University
For direct contact, visit the study record on ClinicalTrials.gov .